Department of Visceral- and Transplant Surgery, University Hospital of Zurich
Zurich, Canton of Zurich, 8091, Switzerland
NCT Number: NCT02132078
The purpose of this study is to assess incidence, treatment modalities and outcome of complicated and uncomplicated diverticulitis in highly immunosuppressed lung transplant recipients (LTRs) in order to establish improved treatment strategies in this high risk patient collective.
Looking for future studies?
Notify MeAll sexes
Observational
Zurich, Canton of Zurich, 8091, Switzerland
Sigmoid diverticulitis is common and potentially problematic in immunosuppressed patients. The choice between conservative and surgical treatment for uncomplicated diverticulitis remains unclear, as well as the value of the Hartmann's procedure (HP) for complicated diverticulitis.
Our aim is to assess incidence, treatment options and outcome of complicated and uncomplicated diverticulitis in highly immunosuppressed lung transplant recipients (LTRs) by retrospectively analysing our prospective database of around 400 lung transplant recipients transplanted between 1992 and 2013.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: January 1992- December 2013 (22 years)
Our aim is to assess incidence, treatment options and outcome of complicated and uncomplicated diverticulitis in highly immunosuppressed lung transplant recipients (LTRs) by retrospectively analysing a prospective database of around 400 LTRs transplanted between 1992 and 2013.
University of Zurich
Other
Long-term Follow-up of Lung Transplant Recipients With Diverticulitis
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06654076
Aspergillosis, Bacterial Infections and Mycoses
View Trial DetailsNCT00284726
Lung Transplant Recipients
View Trial DetailsNCT07035743
Airway Response, Challenge Test
Taoyuan, Taiwan
View Trial DetailsNCT05681559
Digestive System Diseases, Diverticular Diseases
Seattle, Washington, United States
View Trial Details